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Abstract
Background: The infantile form of neuronal ceroid lipofuscinosis (also known as infantile Batten
disease) is caused by hereditary deficiency of a lysosomal enzyme, palmitoyl-protein thioesterase-
1 (PPT1), and is characterized by severe cortical degeneration with blindness and cognitive and
motor dysfunction. The PPT1-deficient knockout mouse recapitulates the key features of the
disorder, including seizures and death by 7–9 months of age. In the current study, we compared
gene expression profiles of whole brain from PPT1 knockout and normal mice at 3, 5 and 8 months
of age to identify temporal changes in molecular pathways implicated in disease pathogenesis.
Results: A total of 267 genes were significantly (approximately 2-fold) up- or downregulated over
the course of the disease. Immediate early genes (Arc, Cyr61, c-fos, jun-b, btg2, NR4A1) were
among the first genes upregulated during the presymptomatic period whereas immune response
genes dominated at later time points. Chemokine ligands and protease inhibitors were among the
most transcriptionally responsive genes. Neuronal survival factors (IGF-1 and CNTF) and a
negative regulator of neuronal apoptosis (DAP kinase-1) were upregulated late in the course of the
disease. Few genes were downregulated; these included the α2 subunit of the GABA-A receptor,
a component of cortical and hippocampal neurons, and Hes5, a transcription factor important in
neuronal differentiation.
Conclusion:  A molecular description of gene expression changes occurring in the brain
throughout the course of neuronal ceroid lipofuscinosis suggests distinct phases of disease
progression, provides clues to potential markers of disease activity, and points to new targets for
therapy.
Background
An unusual group of lysosomal storage disorders, the neu-
ronal ceroid lipofuscinoses, are characterized by retinal
and cortical neurodegeneration with scant autofluores-
cent storage material that accumulates in the brain and
peripheral tissues (reviewed in [1]). Distinct subsets of
NCL are recognized based on characteristic appearance by
electron microscopy that include granular osmiophilic
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deposits and/or various membrane profiles (curvilinear,
fingerprint, and rectilinear) [2]. Autosomal recessive
mutations in at least seven different genes are responsible
for these disorders [3], and while the function of only a
few is known, each appears to participate in some aspect
of endo/lysosomal function [4]. The CLN1 (ceroid lipo-
fuscinosis, neuronal-1) gene encodes a soluble lysosomal
palmitoyl-protein thioesterase (PPT1) that functions to
remove fatty acids (usually palmitate) from modified
cysteine residues in proteins [5,6]. A growing number of
studies implicate PPT1 in the maintenance of synaptic
vesicle number [7] and function [8-10].
The PPT1 knockout mouse is an excellent model for infan-
tile neuronal ceroid lipofuscinosis, recapitulating the
major findings in the disease [11-15]. An orderly series of
pathological events have been described in the central
nervous system of PPT1 deficient mice [16] that includes
localized astrocytosis, first detected between one and
three months of age, with earliest changes detected in the
thalamic relay nuclei of the visual system (dorsal lateral
geniculate nucleus). The progression of neuronal loss pro-
ceeds from thalamic relay neurons to interneurons and
finally, to corresponding target cortical granule neurons.
The observed marked effect on thalamic nuclei in the mice
is consistent with early thalamic hypointensity in MRI
studies of INCL patients [17]. Loss of inhibitory interneu-
rons corresponds temporally with onset of seizures at 7
months. Microglial (macrophage) activation is a promi-
nent feature, first detectable during later stages of disease,
between 3 and 5 months. Death occurs in most animals
by 9 months of age [11,12].
Despite a great deal of understanding at the cellular level,
useful information may be gained from a more detailed
description of the progress of the disorder at the level of
gene expression. In this study we have followed the
expression of approximately 34,000 genes in the brains of
normal and PPT1 deficient mice at three points during the
development of the neurological disorder, and reveal a
transcriptional landscape that will be of value in under-
standing this and other neurodegenerative conditions.
Results
Study design and microarray comparisons
RNA was extracted from whole brains of wild-type and
PPT1 knockout mice at 3, 5, and 8 months of age (three
animals in each group, total of 9 wild-type and 9 knock-
out animals) and hybridized to Affymetrix mouse expres-
sion array 430 2.0 chips to obtain gene expression profiles
of 45,101 probe sets corresponding to 34,000 well-charac-
terized mouse genes.
A gene filter was applied that excluded two classes of
genes: 1) those with detection call 'Absent' that exceeded
80% of the expression data values and 2) those in which
less than 20% of the expression data values had at least a
1.5-fold change in either direction from the median value
of that gene. This filter will select for genes that show rel-
atively large fold-changes (on the order of 1.5-fold or
more) in knockout vs. wild-type. A total of 5236 probe
sets passed filtering, and the microarray data were ana-
lyzed using the algorithm Significance Analysis of Micro-
arrays (SAM) [18] (false discovery rate, 0.05, 1000
permutations, confidence level 90%) (see Methods). A
total of 267 probe sets were identified as significantly dif-
ferentially expressed between the two phenotypes, taken
as a whole (Fig. 1). These probe sets represent 235 unique
named genes (Additional File 1). Among these genes
highly regulated genes, 227 genes were upregulated, and 8
genes were downregulated. A comparison of gene expres-
sion changes between PPT1 knockout and wild-type
showed increased scatter with increasing time at 3, 5, and
8 months, as increasingly more genes were observed to be
over- or underexpressed in PPT1 vs. wild-type mouse
brains (Fig. 2).
A validation experiment was run using a sampling of 14
genes from the list of 267 differentially-expressed genes by
quantitative real-time PCR using the fluorescent dye SYBR
green I (Fig. 3). Two sets of samples were assayed-samples
from the original RNA samples used for the microarray
analysis (18 samples) and a set consisting of a further 18
samples from an independent set of mice. The following
genes were analyzed by RT-PCR to represent both up- and
down-regulated genes of varying levels of expression:
Ctsd, Serpina3n, Lgals, A2m, Lzp-s, C1qa, C4, Cap1, Fos,
Gp49a, Gfap, Erdr1, Ndufs-5, and Mid1 (Fig. 3). The Pear-
son correlation coefficient between the microarray
hybridization data and the quantitative PCR data per-
formed on the original RNA samples was 0.85, and the
Pearson correlation coefficient between the original 18
samples and a second independent validation set of 18
samples was 0.83. These results compare favorably with
previously published studies [19]. However, in one
instance a discordant result was obtained. Mid1, identi-
fied as a highly downregulated gene in the SAM analysis,
was confirmed to be significantly downregulated in the
original sample replication set but not significantly
changed in the separate independent sample of 18 mice
derived from our colony. The explanation for this finding
is not entirely clear; however, it is notable that a high fre-
quency of spontaneous deletion and duplication events
affecting the Mid1 gene (which is located in the geneti-
cally unstable pseudoautosomal region in Mus musculus)
has been reported, affecting 20% of paternal chromo-
somes [20].
Application of an unsupervised clustering algorithm to
the 267 probe sets (Fig. 4) correctly distinguished wild-BMC Neuroscience 2007, 8:95 http://www.biomedcentral.com/1471-2202/8/95
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type and knockout groups and to a large extent found
greater similarities in gene expression changes in animals
with the same age range. The algorithm more sensitively
distinguished age classes in the knockout animals as com-
pared to the wild-type, not surprising given the much
larger number of differentially expressed genes in the
former group. There was a single minor exception in that
one 8-month old knockout animal was clustered more
closely with the 5-month old knockout animals. This
result is consistent with the previously observed slight het-
erogeneity of onset of neurological signs in the knockout
animals at around 5 months of age [11]. Visual inspection
of the results of the clustering analysis (Fig. 4, for full ver-
sion see Additional File 2) revealed several groups of
genes with varying patterns of expression with time; for
example, several genes peaked early and then decreased to
levels below baseline (as in the first three rows of Fig. 4)
while other clusters contained genes upregulated late in
the course of the disease with highest expression at 8
months. (Particularly notable is the large proportion of
interferon-induced genes represented among the list of
significantly differentially expressed genes (see, for
instance, second panel of Fig. 4)). These interesting pat-
terns of gene expression as revealed by cluster analysis led
us to develop individual lists of genes that were signifi-
cantly regulated at pre-symptomatic (3 month), early
symptomatic (5 month) and late symptomatic (8 month)
time points.
Time course of gene expression changes
A comparison of the expression of each differentially
expressed gene between wild-type and PPT1 knockout
mice as a function of age (Fig. 5) showed that while few
genes changed between 3 and 8 months of age in wild-
type mice (Fig. 5, panels A, C, and E), comparisons
between groups of knockout animals showed a much
larger set of genes that changed (particularly increased)
during this time (Fig. 5, panels B, D, and F). Groupwise
comparisons of wild-type vs. PPT1 knockout mice at 3, 5
and 8 months of age revealed 666 probe sets that were dif-
ferentially expressed at (at least) one time point. The rela-
tionships of these probe sets with respect to age are
presented in a Venn diagram (Fig. 6). A complete list of
the 84 probe sets (representing 52 genes) common to all
three age groups is given in Additional File 3.
We hypothesized that certain subsets as indicated in Fig. 6
might provide particular insights into biological processes
affected by PPT1 deficiency. For example, a subset of 56
probe sets (indicated in Fig. 6 in dark shading and listed
in full in Additional File 4) were differentially expressed
(mainly upregulated) in the knockout at 3 months, but
were not identified as significantly changed at either 5 or
8 months in comparison to wild-type. This list of genes
was analyzed using the gene ontology function of the pro-
gram DAVID (The Database for Annotation, Visualiza-
tion, and Integrated Discovery, 2006) [21], which
provides a list of categories of genes that are significantly
enriched in an experimental group as compared to a con-
trol group. These categories, and a list of representative
Scatter plot of gene expression profiles of PPT1 knockout vs. wild-type mouse brain Figure 1
Scatter plot of gene expression profiles of PPT1 knockout vs. wild-type mouse brain. Each point represents a 
unique probe set. Y- and X-axis values are expressed as the logarithm of expression intensity for each probe set. (A) All probe 
sets (a total of 5236) that passed filtering as described under "Materials and Methods" are shown. (B) Probe sets (total of 267) 
yielding a significant difference (as determined by SAM analysis under "Methods" between the average of the knockout and 
wild-type classes are shown.
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Scatter plot of gene expression profiles at 3, 5 and 8 months of age Figure 2
Scatter plot of gene expression profiles at 3, 5 and 8 months of age. Each point represents a unique probe set. Y- and 
X-axis values are expressed as the logarithm of expression intensity for each probe set. (A, C, E) Groupwise comparisons 
between wild-type and PPT1 knockout at 3, 5, and 8 months for all probe sets (5236) that passed filtering as described under 
"Materials and Methods". (B, D, F) Groupwise comparison between wild-type and PPT1 knockout mice showing only those 
probe sets selected by SAM (significance) analysis (total of 267). The scatter plot indicates an increasing number of gene 
expression changes with time in the knockout mice.
3
5
7
9
11
13
3579 1 1 1 3
3
5
7
9
11
13
3 5 7 9 11 13
3
5
7
9
11
13
3579 1 1 1 3
P
P
T
1
-
/
-
P
P
T
1
-
/
-
PPT1+/+
PPT1+/+
AB
3
5
7
9
11
13
3579 1 1 1 3
PPT1+/+
P
P
T
1
-
/
-
PPT1+/+
C
3
5
7
9
11
13
3579 1 1 1 3
PPT1+/+
D
3
5
7
9
11
13
3579 1 1 1 3
P
P
T
1
-
/
-
PPT1+/+
EF
P
P
T
1
-
/
-
P
P
T
1
-
/
-
3 mos
8 mos
5 mos
3 mos
8 mos
5 mosBMC Neuroscience 2007, 8:95 http://www.biomedcentral.com/1471-2202/8/95
Page 5 of 17
(page number not for citation purposes)
genes differentially regulated in the PPT1 knockout vs.
wild-type mice, are listed in Table 1 (see Additional File 4
for a full list of enriched categories, including uncatego-
rized genes). Interestingly, pattern specification and tran-
scription factors were most highly enriched, and five of
these genes have been described as immediate early genes
that are induced in response to central nervous system
injury (Arc, cysteine-rich protein 61, c-Fos, Jun-b, and the
nuclear orphan receptor NR4A1). (A note of caution: one
cannot conclude from this analysis that all genes listed in
Table 1 are exclusively regulated at 3 months; for example,
several genes (for example, Cyr61 and c-Fos show -fold
changes at 5 mo and 8 mo that are similar to those at 3
months; however, there was sufficient animal-to-animal
variability at the later time points that significant regula-
tion at these points could not be confidently predicted
given the limited number of animals analyzed. Inspection
of the raw data (available for download in the Supple-
mentary Material) does suggest that these changes do
decrease with time with respect to Arc, c-fos, NR4A1, and
to some extent, Jun-b).
Table 2 lists significantly enriched categories of all genes
that were up- or downregulated at least two fold in PPT1
knockout mice at 5 months of age as compared to wild-
type (for a full list of categorized and uncategorized genes,
see Additional File 5). Immune response genes domi-
nated this list, and included genes that play a role in the
inflammatory response, response to pathogens, chemo-
taxis, antigen presentation, and positive regulation of
phagocytosis. Complement components, chemokine lig-
ands, immunoglobulin receptors were prominently
upregulated. Protease inhibitors were among the most
highly upregulated genes; for example, serpin3An was
induced approximately 4, 14 and 20-fold at 3, 5 and 8
months in the PPT1 knockout brain. The expression of
cystatin F, α2-macroglobulin, and tissue inhibitor of met-
alloproteinase (TIMP) were also markedly increased.
Genes encoding lysosomal enzymes, such as cathepsins S,
Z, and D were each increased several-fold. The one
remaining significantly-enriched category, water trans-
port, included genes encoding the water channel
aquaporin 4 and podoplanin. Aquaporin 4 [22] is the
major water channel in the brain, expressed predomi-
nantly in astroglial cells, and plays a major role in fluid
clearance in vasogenic brain edema, whereas podoplanin
is a lymphatic endothelial cell marker and has been
reported to be upregulated in astrocytic tumors [23].
Table 3 is a list of enriched categories of genes that were
significantly regulated (at least two-fold) in PPT1 knock-
out mouse brain at only the latest time point (8 months),
when mice showed clear neurological signs (for a full list
containing categorized and uncategorized genes, see
Additional File 6). (It should be noted that gene expres-
sion changes in some of these genes were observed at 3 or
5 months, but did not reach statistical significance until 8
months). The most significantly enriched category
(purine nucleotide metabolism) was comprised of
kinases, GTPases, receptors, transporters, and kinesins,
Validation of a subset of regulated genes by quantitative PCR Figure 3
Validation of a subset of regulated genes by quantita-
tive PCR. Values represent the mean ± standard deviation 
of the -fold change of PPT1 knockout as compared to wild-
type expression (n = 3 for each value). Black bars, values 
obtained from microarray hybridization. Gray bars, values 
obtained from quantitative PCR analysis of the original 18 
samples used for the microarray hybridizations. White bars, 
values obtained from an independent set of 18 samples ana-
lyzed by quantitative PCR. *, off-scale value is 103 ± 0.33 -
fold.
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perhaps reflecting increased signaling and motility of
immune cells in the brain. In support of this idea, most of
the upregulated genes in this category are enriched in
immune cells (for example ABC1, Gimap4), whereas the
downregulated genes are enriched in neural tissue (Uhm
kinase 1, EphRa3), observations consistent with the
inflammatory cell infiltrate and neuronal loss that charac-
terize late stages of neurodegeneration in neuronal ceroid
lipofuscinosis.
Some of the most interesting regulated genes at 8 months
are those categorized as negative regulators of cellular
processes (Table 3). Several of these genes negatively reg-
ulate neuronal apoptosis and serve as neuronal survival
factors, and therefore may be relevant to the amelioration
of Batten disease. Insulin-like growth factor-1 (IGF-1,
upregulated about 3-fold) has been noted to increase in
concentration in the cerebrospinal fluid of patients with
infantile Batten disease [24], and has been used to delay
interneuron loss in the mnd model of Batten disease [25].
Ciliary neurotrophic factor (CNTF, upregulated 3-fold) is
a potent survival factor for neurons and may be important
in reducing tissue destruction following inflammatory
attacks; its expression is restricted to the nervous system
[26]. Death-associated protein kinase 1 (DAPK1, up 2-
fold) is expressed in neurons and overexpressed and acti-
vated in seizure disorders [27]. DAPK1 seems to have a
role in neuronal apoptosis, and has attracted interest as a
Hierarchical clustering of significantly regulated genes Figure 4
Hierarchical clustering of significantly regulated genes. Probe sets represent 18 brain samples from mice at 3, 5, and 8 
months of age. For clarity, only representative portions are shown (55 of 255 probe sets corresponding to 227 genes and all 
downregulated probe sets (12 probe sets corresponding to 8 genes). Upregulated genes are shown in red and downregulated 
genes in green. This figure shows the upper quartile of the image. For the full image depicted in Fig. 4 please see Additional File 
2. Additional File 10 contains full clustering information for all 227 genes.
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Scatter plot of gene expression profiles as a function of age Figure 5
Scatter plot of gene expression profiles as a function of age. Pairwise comparisons of age groups within each pheno-
typic class (control or PPT1 knockout) are shown. Each point represents a unique probe set, and Y- and X-axis values are 
expressed as the logarithm of expression intensity for each probe set. The data set includes all probe sets (a total of 5236) that 
passed filtering as described under "Materials and Methods". Note the increased scatter of data points with age in the PPT1 
knockout with age as compared to the wild type mice.
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drug discovery target for neurodegenerative disease [28].
Other genes in this category may have effects on neurons
and/or their interactions with inflammatory cells. CCAAT-
enhancer binding protein-β (C/EBP-β, up 3-fold) is a tran-
scription factor expressed in neurons that is involved in
the transcriptional activation of acute-phase genes and is
postulated to control the response to inflammation in
neural cells in the brain [29]. It is also implicated in the
activation of axonal regeneration-associated genes [30].
Its role may be complex, as it also regulates the expression
of IGF-1 in macrophage-derived cell lines [31], and IGF-1
is also a potent mitogen for microglial cells [32]. Finally,
Kruppel-like factor 4 (KLF4, up 2-fold) is another tran-
scription factor has a role as a regulator of macrophage
activation, but its role in microglial cells in the nervous
system has not been previously reported [33].
Pathway analysis of unfiltered gene sets
The genes listed in Tables 1, 2, and 3 were identified using
a filtering algorithm that selected for relatively large
changes in gene expression between PPT1 knockout and
wild-type mice. However, for pathway analysis, smaller
changes that occur over larger numbers of gene may pro-
vide a more sensitive indication of affected pathways. For
this reason, we generated a list of significantly regulated
genes (using SAM) that was based on all 45,0101 probe
sets prior to filtering (843 probe sets representing 490
genes) and used this list for gene ontology analysis using
the Webgestalt program, which displays results in a graph-
ical format (directed acyclic graph) [34]. The results are
shown in Fig. 7, 8, 9.
As shown in Fig. 7, a large number of biological processes
(27) were enriched, and all of these can be related to
immune or inflammatory processes. These include
immune response genes (53 genes), leukocyte activation
(19 genes), chemotaxis (17 genes), and phagocytosis (8
genes), among others. The molecular function ontology
category (Fig. 8) identified significantly enriched catego-
ries that were dominated by cytokine and chemokine
activity. One interesting category, calcium-dependent
phospholipid binding (6 genes) contained five annexins
which were upregulated in the brains of PPT1 deficient
mice. Annexins play a variety of roles in membrane asso-
ciation events that link calcium signaling and membrane
dynamics [35] and participate in modulating signals to
phagocytes during apoptotic cell death [36]. The third
ontology category, cellular component (Fig. 9), shows
enrichment of regulated genes classified as belonging to
the extracellular space (121 genes) and lysosome (28
genes). Prominently upregulated members of the extracel-
lular space class included serine protease inhibitors and
cytokines. Genes encoding lysosomal proteins are upreg-
ulated and are listed in Additional File 7. Enrichment of
this category probably reflects recruitment of phagocytic
cells (which are rich in lysosomal enzymes) into the brain,
and also a compensatory increase in remaining lysosomal
enzymes that has been described previously in lysosomal
enzyme deficiencies [37].
Discussion
In the current study, we present a molecular description of
gene transcript changes during the course of a severely
neurodegenerative disease in whole mouse brain. The
changes reflect evolution of an inflammatory disease
process with distinct components at early, intermediate
and late stages of disease.
It was striking that genes identified as significantly upreg-
ulated at 3 months were dominated by those previously
classified as immediate-early genes in the central nervous
system [38,39]. In our study, these included c-fos, jun-b,
Venn diagram of gene expression profiles as a function of age Figure 6
Venn diagram of gene expression profiles as a func-
tion of age. Comparisons between data sets from wild-type 
and PPT1 knockout mice at 3, 5 and 8 months of age were 
made and probe sets having p-values of less than 0.005 (two 
sample t-tests, random variance version) were considered 
significant. The resulting gene lists were further used to con-
struct a Venn diagram (in GeneSpring) [57] to identify genes 
potentially uniquely expressed at the three different ages. 
Complete gene lists are available in Additional Files 4, 5, and 
6.
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btg2, the nuclear orphan receptor NRF4a, Arc, and Cyr61.
Immediate early genes are defined as the first group of
genes to be expressed (in this case, in neurons) following
specific extracellular signals, and are operationally
defined as those RNAs expressed in the presence of pro-
tein synthesis inhibitors and hence do not require protein
synthesis for their transcription. They include regulatory
transcription factors, structural and scaffolding proteins,
signaling molecules and growth factors, and some of
them (such as c-fos and Arc) are now widely used as activ-
ity markers for mapping neuronal circuitry [40]. The
mechanism for their activation in PPT1 deficiency is not
undefined. It has been demonstrated that immediate early
gene induction is not consistently coupled to simple met-
abolic activity or to stress or stimulation [39], and is pos-
tulated to play an integrative role in establishing brain
circuitry. It is interesting and perhaps unexpected that a
lysosomal enzyme deficiency would lead to such changes,
suggesting a potential role for the lysosome in the main-
Table 1: Enriched categories – genes significantly up- or down-regulated at 3 months (but not significant at 5 or 8 months)
Enriched Category (p-value) Subcategory Examples 3 mo 5 mo 8 mo
(-fold change)
Pattern Specification (p < 0.0023) Immediate early genes aArc 3.5 2.7 1.0
aCysteine-rich protein 61 3.0 1.8 4.5
Zbtb16 -2.4 -1.3 1.8
Transcription (p < 0.015) Immediate early genes ac-Fos 2.9 3.6 2.4
btg2 2.7 1.2 1.1
aNR4A1 2.3 2.1 -1.1
aJun-b 1.7 1.9 1.5
Response to DNA Damage Stimulus (p < 0.021) DNA replication and stress response hmg2 2.0 1.3 2.2
PCNA -1.8 1.1 1.1
Sgk1 -2.3 1.1 2.4
aReported to be immediate-early response genes expressed in central nervous system
Table 2: Enriched categories – genes significantly up- or down-regulated at 5 months
Enriched Category (p-value) Subcategory Examples 3 mo 5 mo 8 mo
(-fold change)
Immune Response (p < 6.8 × 10-28) Complement aC4b 4.8 10.1 8.6
components aC3 1.2 6.5 14.7
C1q 2.3 2.6 3.2
Chemotaxis aCXCL21 11.4 9.9 6.9
aCXCL10 7.5 8.3 6.7
aCXCL12 3.4 7.4 4.4
aCXCL5 2.3 6.1 2.3
aCXCL3 2.4 3.8 2.8
dCXCL6 2.9 2.8 1.8
aIntegrin β2 1.6 3.3 4.6
aIntegrin αx 2.3 3.8 5.2
Phagocytosis aClec7a 10.3 13.6 14.7
Immunoglobulin aFc receptor, IgG 2.7 4.5 6.9
Receptors
Protease inhibitors a,bSerpin3An 4.3 13.8 20.3
aCystatin F 5.3 12.0 13.6
α2-macroglobulin 1.3 3.1 5.0
TIMP 1.5 2.9 6.9
Lysosome (p < 0.0034) Cathepsins aCathepsin S 2.1 2.4 2.7
a,dCathepsin Z 1.7 2.3 2.3
aCathepsin D 1.5 2.1 2.7
Water Transport (p < 0.017) Aquaporins and related c,dAquaporin 4 1.5 2.5 2.4
Podoplanin 1.6 2.8 2.8
aReported to be highly expressed in immune cells
bReported to be highly expressed in neuronal cells
cReported to be highly expressed in astrocytes
dResults from one probe set from two or more showing similar resultsBMC Neuroscience 2007, 8:95 http://www.biomedcentral.com/1471-2202/8/95
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tenance of neuronal circuitry that may go awry when lys-
osomal integrity is not maintained.
It is notable that few genes were significantly downregu-
lated in the course of the disorder. One might have
expected to see a more striking decline in neuron-specific
proteins to parallel the observed neuronal loss described
in the disease. One possible explanation is that many of
these proteins are expressed only at low levels and in
small populations of cells, and so downregulation of
these low-level transcripts would not reach statistical sig-
nificance. However, a significant decline in the transcript
encoding the α2 subunit of the GABA-A receptor was
noted. This major GABA receptor subunit is highly
enriched in cortical and hippocampal pyramidal cells
[41], which are major affected cell types in PPT1 defi-
ciency [42]. Hes5 (downregulated 3-fold at 8 months) is a
transcription factor involved in notch-mediated neuronal
differentiation [43]; its loss perhaps reflects a depletion of
neuronal stem cells late in the course of the disease. As
expected, transcripts encoding PPT1 were severely
depressed. (Unexpected results concerning the CAP1 gene
(adenylate cyclase associated protein) were obtained, with
up- or down-regulation observed, depending on which
probe sets were used for analysis. The 3' untranslated
regions of the CAP1 and PPT1 genes partially overlap, sug-
gesting that CAP1 mRNA splicing or stability may have
been affected as a consequence of the PPT1 exon 9 disrup-
tion, which covers a portion of the 3'UTR. These changes
were not examined in further detail).
Table 3: Enriched categories – genes significantly up- or down-regulated at 8 months (but not significant at 3 or 5 months)
Enriched Category (p-value) Subcategory Examples 3 mo 5 mo 8 mo
(-fold change)
Purine Nucleotide (p < 0.00025) Kinases av-yes homolog -1.1 1.5 2.7
CaM kinase-4 1.2 -1.1 2.5
B-Raf 1.1 1.1 2.3
DAP-kinase 1 -1.2 1.3 2.1
bUhm Kinase 1 1.0 -1.3 -2.5
GTPases RhoC 1.3 1.5 2.4
Era1 1.8 -1.1 2.3
aGimap4 2.2 1.1 2.3
Receptors EDG3 1.9 2.2 2.5
bEphRa3 1.7 -1.0 -2.7
Transporters aABC1 1.7 1.9 2.3
bABCA8a -1.6 -1.2 -2.1
Kinesins Kinesin 18a -1.2 1.7 2.1
bKinesin 5a/c 1.0 -1.3 -2.0
Negative Regulators Of Cellular Processes (p < 0.0037) Transcription Factors a,bC/EBP-β 1.3 1.4 2.6
a,bC/EBP-α 1.1 1.4 2.2
aKruppel-like 4 1.3 1.8 2.1
Midline -1.9 -1.5 -2.2
bHes5 1.2 -1.1 -3.3
Growth Factors aIGF-1 1.6 1.6 3.2
a,bCNTF 1.4 1.5 2.8
Signaling aRGS-1 1.2 2.0 5.0
RGS-2 1.2 1.0 2.2
bAA 8 lipoxygenase -1.5 -1.1 -2.2
Intracellular Transport (p < 0.013) Proton/Solute Carriers a,bUCP2 -1.8 -1.0 3.2
Slc1a3 (glial) -1.3 1.2 2.6
Nuclear Transport Nucleoporin214 -1.0 1.1 2.6
Ipoll -1.0 -1.0 2.4
Positive Regulators Of Cellular Processes (p < 0.018) Transcription Factors bAtonal homolog-1 -2.0 1.3 -2.4
aNFAT5 1.2 1.1 -2.8
Cell Adhesion (p < 0.018) Cell surface aICAM 1.8 2.5 5.4
aCD44 1.2 2.4 4.5
Annexin A9 1.7 1.2 3.0
Extracellular matrix Procollagen ivα51 . 2 1 . 7 2 . 9
Transglutaminase 2c 1.4 1.6 2.2
aReported to be highly expressed in immune cells
bReported to be highly expressed in neuronal cellsBMC Neuroscience 2007, 8:95 http://www.biomedcentral.com/1471-2202/8/95
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Gene expression profiles of diseased brain or spinal cord
that have been previously reported provide important
points for comparison. In a previous study of an infantile
Batten disease mouse model (PPT1Δexon 4) [14] in which
4000 genes were examined at a single time point (6
months), an upregulation of inflammatory genes con-
comitant with an inflammation-associated loss of
interneurons was observed. A total of 51 genes were found
in common (with 5 month time point) [14], suggesting
that the findings described here are quite robust. A second
more limited study of mouse PPT1 knockout brain at a
very early time point (6 weeks) revealed few changes,
although an elevation in GFAP was reported [44]. The
presence of microglial (macrophage) activation is well
documented as a feature of other lysosomal storage disor-
ders. For example, Ohmi, et al. [45] observed prominent
microglial infiltration and macrophage activation in
mouse models of mucopolysaccharidoses I and IIIb.
Many of the most striking gene changes were also
observed in our data set: for example, prominent upregu-
lation of CD68/macrosialin, complement components
C4 and C1q, lysozyme, cathepsins C, H, S, and Z, DAP12/
tyrobp, Mpeg1, serpina3n, and GFAP were reported. In
the Sandhoff disease mouse model [46], microglial activa-
tion was shown to precede neurodegeneration and was
associated with upregulation of macrophage markers
CD68/macrosialin, galectin 3, cathepsins S and C, Mpeg1,
and glycoprotein49a, which we also observed. Astroglial
markers reported in common with our data were seen in
Niemann-Pick (acid sphingomyelinase) knockout mice
[47], such as GFAP and aquaporin. In this study, serum
markers for the disease process were sought, and chemok-
ines and their ligands were considered promising.
A number of chemokines were highly upregulated in the
PPT1 deficient mouse brain, with chemokine ligand 21
(Ccl21a/b/c) being upregulated 10-fold. The receptor for
Ccl21 ligands, CC chemokine receptor 7 (CCR7), is selec-
tively expressed on mature dendritic cells. Ccl21 facilitates
migration of mature dendritic cells from peripheral tissues
to regional lymph nodes and enhances receptor-mediated
endocytosis by these cells [48]. Its use as a serum marker
for disease has not been described; furthermore, it would
be interesting to know the effect of specific chemokine
antagonism on the neurodegenerative process and
whether even non-specific immune suppressants would
have an effect on the disease. This point would seem par-
ticularly important as neural stem cell therapies are cur-
rently under development and current protocols include
immunosuppression as part of the treatment. Production
of lysophosphatidylcholine (lyso-PC) by cPLA2 in the
brain of mice lacking PPT1 has been demonstrated and
was proposed as a signal for phagocyte infiltration [49]. In
this regard, we note that a lysophospholipid receptor,
Edg3, was highly upregulated in our samples, suggesting
another avenue for blockade of the immunological
response. However, whether or not immune modulation
(in the absence of correction of the primary defect) would
Directed acyclic graph of gene ontology biological process categories Figure 7
Directed acyclic graph of gene ontology biological process categories. A list of 490 significantly regulated genes (from 
843 probe sets as determined by SAM prior to filtering) was compared to the entire 49,101 probe set with respect to gene 
ontology category using the Webgestalt program as described under Methods. Only the significantly enriched (p < 0.001) bio-
logical process categories are shown.
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impact disease progression remains highly speculative at
this point.
It should be emphasized that the gene expression changes
we observed represent a global pathological process and
includes not only changes in the neuronal population but
also the infiltration by macrophages and an increase in
glial cells. Gene expression changes in PPT1 knockout pri-
mary neuronal cultures were recently reported [50]; 106
genes upregulated and 29 downregulated genes were
identified. In this study, cholesterol biosynthetic genes
were modestly upregulated, a finding supported by a two-
fold increase in cholesterol synthetic rate in the cultured
cells. In our study, we did observe a striking increase in
cholesterol 25-hydroxylase, of about 5-fold. This enzyme
is involved in cholesterol metabolism by macrophages,
we postulate that it may be needed for membrane turno-
ver and cholesterol disposal in this neurodegenerative
process. Cholesterol biosynthesis was not identified as a
significantly enriched pathway in our analysis, and the
changes in the five cholesterol biosynthetic genes
observed in the in vitro study were not significant in our
whole brain samples (data not shown).
Several comprehensive microarray-based datasets similar
to the current study have recently become available for
non-lysosomal neurodegenerative mouse models, such as
Huntington disease [51], spinocerebellar ataxia [52], and
epilepsy (calcium channelopathy "stargazer" mice) [53].
When we collated these data into BRB Array Tools with
the same filtering criteria and normalization methods as
Directed acyclic graph of gene ontology cellular component  categories Figure 9
Directed acyclic graph of gene ontology cellular com-
ponent categories. A list of 490 significantly regulated 
genes (from 843 probe sets as determined by SAM prior to 
filtering) was compared to the entire 49,101 probe set with 
respect to gene ontology category using the Webgestalt pro-
gram as described under Methods. Only the significantly 
enriched (p < 0.001) cellular component categories are 
shown.
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described above, surprisingly few genes (only one or two;
for example upregulation of the immediate early gene
egr2 in Huntington disease and CD52 and GFAP in the
"stargazer" mice) were significantly regulated in common
with our lysosomal storage disease mouse model (data
not shown). Future comparisons between different mouse
models of neurodegenerative disease and other disease
processes promise to be enlightening as more data
become available.
Conclusion
Gene expression profiling of brains from PPT1 knockout
mice showed a number of significant differences from
wild-type. Immediate early genes (Arc, Cyr61, c-fos, jun-b,
btg2, NR4A1) were significantly up regulated at early
stages of the disease. Markers of an intense inflammatory
response, noted at 5 and 8 months, may be somewhat
unique to PPT1 deficiency and other lysosomal storage
diseases and were not shared by several other available
neurodegenerative disease models. Chemokine ligands
were highly upregulated, and may provide potential
serum markers for disease activity. Neuronal survival fac-
tors (IGF-1 and CNTF) and a negative regulator of neuro-
nal apoptosis (DAP kinase-1) were upregulated. Few
genes were significantly downregulated, which may seem
inconsistent with the observed neuronal loss described in
the disease. However, significant downregulation of the
GABA-A2 receptor was observed, a finding consistent with
the loss of GABA-ergic cortical and hippocampal neurons
previously described in the disorder. Identification of key
negative regulatory molecules in the process of neurode-
generation provides a number of avenues for further
exploration and may therefore eventually lead to new
therapies.
Methods
Brain samples and RNA purification
Homozygous  Ppt1tm1Hof-/- mice were maintained in the
animal facility at the University of Texas Southwestern
Medical Center, Dallas, Texas, USA, as described previ-
ously [7]. The knockout was produced through targeted
deletion of exon 9 of PPT1, which contains a portion of
the enzyme active site, and results in no detectable
enzyme activity or immunoreactivity [11]. The mice were
bred for more than 17 generations onto the C57BL6/J
background strain. C57BL6/J mice were from Harlan
Sprague Dawley, Inc. (Indianapolis, IN). Sex-matched
(except for one discordant pair, see below) knockout and
wild-type mice were sacrificed under CO2 at 3, 5 and 8
months of age and whole brains were collected in liquid
nitrogen and stored at -80°C until RNA extraction was
performed. Total RNA was isolated using the RNeasy
Lipid Tissue Midi kit (Qiagen, Valencia, CA) and quanti-
tated following the manufacture's guidelines. Three
mouse brains were analyzed for each data point (total of
18 determinations).
cDNA microarrays
Microarrays were hybridized by arrangements through the
NIH Neuroscience Microarray Consortium [54]. Affyme-
trix mouse expression array 430 2.0 chips were used and
data was acquired using GCOS v1.4 software (Affymetrix).
Signal intensities were scaled to a target intensity of 150 to
facilitate interarray comparisons. The intensity level of
each gene and a detection call ('Present', 'Absent', or 'Mar-
ginally' expressed) were generated using the Statistical
Algorithm [55]. All .CEL, .CHP, and signal call files are
available for download in Additional File 8, and all raw
data are available in the Gene Expression Omnibus [51],
record no. GSE6678.
Filtering and normalization
Probe-set level data generated by GCOS v1.4 software
(Affymetrix) was collated into the software package BRB
Array Tools, developed by the Biometric Research Branch
of the U.S. National Cancer Institute [56]. Spot filter, nor-
malization, and gene filter algorithms were applied to the
microarray signal data sequentially. Spot filter threshold
values were set to a minimum value (10) if the intensity
fell below the minimum. Array normalization was per-
formed by using the median array as the reference array.
For certain analysis as indicated in the text, a gene filter
was applied that excluded two classes of genes: 1) those
with detection call 'Absent' that exceeded 80% of the
expression data values and 2) those in which less than
20% of the expression data values had at least a 1.5-fold
change in either direction from the median value of that
gene.
Data analysis and statistics
Microarray data analyses were performed using the soft-
ware package BRB Array Tools [56], which included Clus-
ter 3.0, and TreeView programs. BRB Array Tools was
implemented for statistical analysis of microarray data,
whereas Cluster 3.0 and TreeView were used for cluster
analysis, using the "average linkage" clustering algorithm
(similarity of correlation-uncentered). Venn diagrams
were generated using the GeneSpring GX 7.3.1 Technol-
ogy Platform [57]. Functional enriched categories analysis
was carried out using DAVID [21] and Webgestalt [34].
Pathway analysis was performed using the MetaCore soft-
ware by GeneGo [58] and DAVID.
Microarray data were analyzed by Significance Analysis of
Microarrays (SAM) (false discovery rate, 0.05, 1000 per-
mutations, confidence level 90%) to identify probe sets
differentially expressed in PPT1 knockout as compared to
wild-type mice. SAM was applied using either all 45,101
probe sets (resulting in a list of 490 significantly regulatedBMC Neuroscience 2007, 8:95 http://www.biomedcentral.com/1471-2202/8/95
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genes) or using 5326 probe sets after filtering (resulting in
267 probe sets representing genes with a higher degree
(greater than about 1.5-fold) of regulation. Pathway anal-
ysis for the more selective SAM list was performed using
the MetaCore software by GeneGo [58]. In addition, two
sample t-tests were performed between wild-type and
PPT1 knockout mice at 3, 5 and 8 months of age. Probe
sets having p-values of less than 0.005 were considered
significant. The resulting gene lists were further used to
construct a Venn diagram (in GeneSpring) [57] to identify
genes overlapping or non-overlapping gene sets signifi-
cantly expressed at the three different ages.
Unsupervised clustering of the 5326 probe sets from 18
arrays revealed 18 gender-specific genes (all previously
reported as sex-linked) and further revealed that one of
the nine pairs of animals (from the 8 month group) was
discordant for sex. (Each experimental group consisted of
one male and two females, with the exception of the 8
month knockout, which had two males and one female).
This finding prompted a more detailed analysis to deter-
mine the effect of this one instance of gender discrepancy.
A t-test using a "leave out one sample" analysis was per-
formed on all combinations for 8-month old mice. In all,
six t-test results were generated in this way. The t-test
results (yielding lists of significantly regulated genes) were
compared by Venn diagram, and were found to be indis-
tinguishable from similar "leave one out" analyses per-
formed using data sets from 3-month-old and 5-month-
old mice, suggesting that the one instance of gender mis-
match did not have a discernible impact on the overall
results.
An initial analysis of functional enriched categories was
carried out on the filtered gene set based on the Gene
Ontology (GO) database terms using DAVID [21]. Cate-
gories with an enrichment score yielding a p-value < 0.05
were considered significant. Analysis of the unfiltered
SAM gene set (843 probe sets representing 490 genes),
used in the construction of the directed acyclic graphs, was
performed using Webgestalt [34] to identify enriched
pathways at a significance level of p < 0.001.
Validation of gene expression changes by quantitative 
real-time PCR
A sampling of 14 genes from the SAM list of 267 differen-
tially-expressed genes were assayed by quantitative real-
time PCR using the fluorescent dye SYBR green I. Two sets
of samples were assayed-samples from the original RNA
samples used for the microarray analysis (18 samples)
and a validation set consisting of a further 18 samples.
Total RNA (4 μg) was reverse transcribed with random
hexamer primers (Invitrogen) and Superscript II (Invitro-
gen) according to the directions supplied by the manufac-
turer. The following genes were analyzed by RT-PCR: Ctsd,
Serpina3n, Lgals, A2m, Lzp-s, C1qa, C4, Cap1, Fos,
Gp49a, Gfap, ErdrI, Ndufs-3, and MidI. Primers sequences
are shown in Additional File 9. The reactions were per-
formed using the 2× Power SYBR® Green PCR Master Mix
(Applied Biosystems) and 100–300 nM of primer (see
Additional File 9 for details). Assays were performed in
triplicate, and analyzed using an ABI 7300 instrument
(Applied Biosystems). The primers were either designed
using a commercially available program (Primer Express,
Applied Biosystems) or obtained from an online database
(Primer Bank) [59]. Primer specificity was assessed by
analyzing amplicon dissociation curves for each sample.
The relative mRNA level was calculated using either the
comparative Ct method (if the PCR amplification effi-
ciency of the gene and β-Actin were equivalent) or the rel-
ative standard curve method (if the PCR efficiency of the
gene and β-Actin were not equivalent), and normalized
against one housekeeping gene (β-Actin).
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Click here for file
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2202-8-95-S10.zip]BMC Neuroscience 2007, 8:95 http://www.biomedcentral.com/1471-2202/8/95
Page 16 of 17
(page number not for citation purposes)
11. Gupta P, Soyombo AA, Atashband A, Wisniewski KE, Shelton JM,
Richardson JA, Hammer RE, Hofmann SL: Disruption of PPT1 or
PPT2 causes neuronal ceroid lipofuscinosis in knockout
mice.  Proc Natl Acad Sci U S A 2001, 98(24):13566-13571.
12. Gupta P, Soyombo AA, Shelton JM, Wilkofsky IG, Wisniewski KE,
Richardson JA, Hofmann SL: Disruption of PPT2 in mice causes
an unusual lysosomal storage disorder with neurovisceral
features.  Proc Natl Acad Sci U S A 2003, 100(21):12325-12330.
13. Wendt KD, Lei B, Schachtman TR, Tullis GE, Ibe ME, Katz ML:
Behavioral assessment in mouse models of neuronal ceroid
lipofuscinosis using a light-cued T-maze.  Behav Brain Res 2005,
161(2):175-182.
14. Jalanko A, Vesa J, Manninen T, von Schantz C, Minye H, Fabritius AL,
Salonen T, Rapola J, Gentile M, Kopra O, Peltonen L: Mice with
Ppt1(Deltaex4) mutation replicate the INCL phenotype and
show an inflammation-associated loss of interneurons.  Neu-
robiol Dis 2005, 18(1):226-241.
15. Griffey MA, Wozniak D, Wong M, Bible E, Johnson K, Rothman SM,
Wentz AE, Cooper JD, Sands MS: CNS-directed AAV2-mediated
gene therapy ameliorates functional deficits in a murine
model of infantile neuronal ceroid lipofuscinosis.  Mol Ther
2006, 13(3):538-547.
16. Kielar C, Maddox L, Bible E, Pontikis CC, Macauley SL, Griffey MA,
Wong M, Sands MS, Cooper JD: Successive neuron loss in the
thalamus and cortex in a mouse model of infantile neuronal
ceroid lipofuscinosis.  Neurobiol Dis 2007, 25(1):150-162.
17. Autti T, Raininko R, Santavuori P, Vanhanen SL, Poutanen VP, Haltia
M: MRI of neuronal ceroid lipofuscinosis. II. Postmortem MRI
and histopathological study of the brain in 16 cases of neuro-
nal ceroid lipofuscinosis of juvenile or late infantile type.  Neu-
roradiology 1997, 39(5):371-377.
18. Tusher VG, Tibshirani R, Chu G: Significance analysis of micro-
arrays applied to the ionizing radiation response.  Proc Natl
Acad Sci U S A 2001, 98(9):5116-5121.
19. Wang Y, Barbacioru C, Hyland F, Xiao W, Hunkapiller KL, Blake J,
Chan F, Gonzalez C, Zhang L, Samaha RR: Large scale real-time
PCR validation on gene expression measurements from two
commercial long-oligonucleotide microarrays.  BMC Genomics
2006, 7:59.
20. Dal Zotto L, Quaderi NA, Elliott R, Lingerfelter PA, Carrel L, Valsec-
chi V, Montini E, Yen CH, Chapman V, Kalcheva I, Arrigo G, Zuffardi
O, Thomas S, Willard HF, Ballabio A, Disteche CM, Rugarli EI: The
mouse Mid1 gene: implications for the pathogenesis of Opitz
syndrome and the evolution of the mammalian pseudoauto-
somal region.  Hum Mol Genet 1998, 7(3):489-499.
21. National Institute of Allergy and Infectious Diseases NIH: The Data-
base for Annotation, Visualization and Integrated Discovery
2006.   [http://niaid.abcc.ncifcrf.gov/home.jsp].
22. Papadopoulos MC, Manley GT, Krishna S, Verkman AS: Aquaporin-
4 facilitates reabsorption of excess fluid in vasogenic brain
edema.  FASEB J 2004, 18(11):1291-1293.
23. Shibahara J, Kashima T, Kikuchi Y, Kunita A, Fukayama M: Podo-
planin is expressed in subsets of tumors of the central nerv-
ous system.  Virchows Arch 2006, 448(4):493-499.
24. Riikonen R, Vanhanen S, Tyynela J, Santavuori P, Turpeinen U: CSF
insulin-like growth factor-1 in infantile neuronal ceroid lipo-
fuscinosis.  Neurology 2000, 54(9):1828-1832.
25. Cooper JD, Messer A, Feng AK, Chua-Couzens J, Mobley WC:
Apparent loss and hypertrophy of interneurons in a mouse
model of neuronal ceroid lipofuscinosis: evidence for partial
response to insulin-like growth factor-1 treatment.  J Neurosci
1999, 19(7):2556-2567.
26. Dallner C, Woods AG, Deller T, Kirsch M, Hofmann HD: CNTF
and CNTF receptor alpha are constitutively expressed by
astrocytes in the mouse brain.  Glia 2002, 37(4):374-378.
27. Henshall DC, Schindler CK, So NK, Lan JQ, Meller R, Simon RP:
Death-associated protein kinase expression in human tem-
poral lobe epilepsy.  Ann Neurol 2004, 55(4):485-494.
28. Bialik S, Kimchi A: The death-associated protein kinases: struc-
ture, function, and beyond.  Annu Rev Biochem 2006, 75:189-210.
29. Cortes-Canteli M, Wagner M, Ansorge W, Perez-Castillo A: Micro-
array analysis supports a role for ccaat/enhancer-binding
protein-beta in brain injury.  J Biol Chem 2004,
279(14):14409-14417.
30. Nadeau S, Hein P, Fernandes KJ, Peterson AC, Miller FD: A tran-
scriptional role for C/EBP beta in the neuronal response to
axonal injury.  Mol Cell Neurosci 2005, 29(4):525-535.
31. Wessells J, Yakar S, Johnson PF: Critical prosurvival roles for C/
EBP beta and insulin-like growth factor I in macrophage
tumor cells.  Mol Cell Biol 2004, 24(8):3238-3250.
32. O'Donnell SL, Frederick TJ, Krady JK, Vannucci SJ, Wood TL: IGF-I
and microglia/macrophage proliferation in the ischemic
mouse brain.  Glia 2002, 39(1):85-97.
33. Feinberg MW, Cao Z, Wara AK, Lebedeva MA, Senbanerjee S, Jain
MK: Kruppel-like factor 4 is a mediator of proinflammatory
signaling in macrophages.  J Biol Chem 2005,
280(46):38247-38258.
34. Zhang B, Kirov S, Snoddy J: WebGestalt: an integrated system
for exploring gene sets in various biological contexts.  Nucleic
Acids Res 2005, 33(Web Server issue):W741-8.
35. Gerke V, Creutz CE, Moss SE: Annexins: linking Ca2+ signalling
to membrane dynamics.  Nature reviews 2005, 6(6):449-461.
36. Munoz LE, Frey B, Pausch F, Baum W, Mueller RB, Brachvogel B,
Poschl E, Rodel F, von der Mark K, Herrmann M, Gaipl US: The role
of annexin A5 in the modulation of the immune response
against dying and dead cells.  Current medicinal chemistry 2007,
14(3):271-277.
37. Tyynela J, Sohar I, Sleat DE, Gin RM, Donnelly RJ, Baumann M, Haltia
M, Lobel P: A mutation in the ovine cathepsin D gene causes
a congenital lysosomal storage disease with profound neuro-
degeneration.  Embo J 2000, 19(12):2786-2792.
38. Lanahan A, Worley P: Immediate-early genes and synaptic
function.  Neurobiol Learn Mem 1998, 70(1-2):37-43.
39. Clayton DF: The genomic action potential.  Neurobiol Learn Mem
2000, 74(3):185-216.
40. Guzowski JF, Miyashita T, Chawla MK, Sanderson J, Maes LI, Houston
FP, Lipa P, McNaughton BL, Worley PF, Barnes CA: Recent behav-
ioral history modifies coupling between cell activity and Arc
gene transcription in hippocampal CA1 neurons.  Proc Natl
Acad Sci U S A 2006, 103(4):1077-1082.
41. Mohler H: GABA(A) receptor diversity and pharmacology.
Cell and tissue research 2006, 326(2):505-516.
42. Bible E, Gupta P, Hofmann SL, Cooper JD: Regional and cellular
neuropathology in the palmitoyl protein thioesterase-1 null
mutant mouse model of infantile neuronal ceroid lipofusci-
nosis.  Neurobiol Dis 2004, 16(2):346-359.
43. Kageyama R, Ohtsuka T, Hatakeyama J, Ohsawa R: Roles of bHLH
genes in neural stem cell differentiation.  Exp Cell Res 2005,
306(2):343-348.
44. Elshatory Y, Brooks AI, Chattopadhyay S, Curran TM, Gupta P, Ram-
alingam V, Hofmann SL, Pearce DA: Early changes in gene expres-
sion in two models of Batten disease.  FEBS Lett 2003, 538(1-
3):207-212.
45. Ohmi K, Greenberg DS, Rajavel KS, Ryazantsev S, Li HH, Neufeld EF:
Activated microglia in cortex of mouse models of mucopol-
ysaccharidoses I and IIIB.  Proc Natl Acad Sci U S A 2003,
100(4):1902-1907.
46. Wada R, Tifft CJ, Proia RL: Microglial activation precedes acute
neurodegeneration in Sandhoff disease and is suppressed by
bone marrow transplantation.  Proc Natl Acad Sci U S A 2000,
97(20):10954-10959.
47. Dhami R, Passini MA, Schuchman EH: Identification of novel
biomarkers for Niemann-Pick disease using gene expression
analysis of acid sphingomyelinase knockout mice.  Mol Ther
2006, 13(3):556-564.
48. Kikuchi K, Yanagawa Y, Onoe K: CCR7 ligand-enhanced phago-
cytosis of various antigens in mature dendritic cells-time
course and antigen distribution different from phagocytosis
in immature dendritic cells.  Microbiol Immunol 2005,
49(6):535-544.
49. Zhang Z, Lee YC, Kim SJ, Choi MS, Tsai PC, Saha A, Wei H, Xu Y,
Xiao YJ, Zhang P, Heffer A, Mukherjee AB: Production of lyso-
phosphatidylcholine by cPLA2 in the brain of mice lacking
PPT1 is a signal for phagocyte infiltration.  Hum Mol Genet
2007.
50. Ahtiainen L, Kolikova J, Mutka AL, Luiro K, Gentile M, Ikonen E, Khi-
roug L, Jalanko A, Kopra O: Palmitoyl protein thioesterase 1
(Ppt1)-deficient mouse neurons show alterations in choles-
terol metabolism and calcium homeostasis prior to synaptic
dysfunction.  Neurobiol Dis 2007.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Neuroscience 2007, 8:95 http://www.biomedcentral.com/1471-2202/8/95
Page 17 of 17
(page number not for citation purposes)
51. Gene Expression Omnibus   [http://www.ncbi.nlm.nih.gov/geo]
52. NIH Neuroscience Microarray Consortium    [http://arraycon
sortium.tgen.org/np2/viewProject.do?action=viewProject&projec
tId=89]
53. NIH Neuroscience Microarray Consortium   [http://arraycon
sortium.tgen.org/np2/viewProject.do?action=viewProject&projec
tId=264940]
54. NIH Neuroscience Microarray Consortium [http://arraycon-
sortium.tgen.org/np2/home.do].  .
55. Affymetrix I: Statistical Algorithms Reference Guide.   [http://
www.affymetrix.com/support/technical/technotes/
statistical_reference_guide.pdf].
56. Biometric Research Branch (U.S. National Cancer Institute): BRB
Array Tools .   [http://linus.nci.nih.gov/BRB-ArrayTools.html].
57. Technologies A: Genespring Technology Platform.
[http:www.chem.agilent.com/Scripts/Generic.ASP?lPage=35082&ind
col=Y&prodcol=Y].
58. GeneGo I: Metacore Software.   [http://www.genego.com/meta
core.php].
59. Massachusetts General Hospital CCIB Harvard Medical School:
Primer Bank.   [http://pga.mgh.harvard.edu/primerbank/].
60. Java TreeView   [http://jtreeview.sourceforge.net/]